SHR0302 Helps Clear Severe AD, Study Says
https://unsplash.com/photos/tWTFjznQlBA

SHR0302 Helps Clear Severe AD, Study Says

According to MedPage Today, data from a preliminary study evaluating SHR0302, an investigational Janus kinase 1 (JAK1) inhibitor, showed promise for treating patients with moderate-to-severe atopic dermatitis (AD). Following treatment,…

Continue Reading SHR0302 Helps Clear Severe AD, Study Says